More SEC Filings
View Older Stories View Newer Stories-
Form 4 Accenture plc For: Mar 05 Filed by: Walsh John F
-
Form 3 5E Advanced Materials, For: Mar 05 Filed by: BEP Special Situations IV LLC
-
Form SCHEDULE 13D/A 5E Advanced Materials, Filed by: Bluescape Energy Partners IV GP LLC
-
Form 8-K NOODLES & Co For: Mar 06
-
Form 8-K Silvercrest Asset Manage For: Mar 06
-
Form 4 ZimVie Inc. For: Mar 04 Filed by: Heppenstall Richard
-
Form 24F-2NT PIONEER SERIES TRUST II For: Dec 31
-
Form 144 Sunrun Inc. Filed by: Jurich Lynn Michelle
-
Form 144 SEMTECH CORP Filed by: Lin Mark
-
Form 4 SUTRO BIOPHARMA, INC. For: Mar 04 Filed by: NEWELL WILLIAM J
-
Form 4 Accenture plc For: Mar 05 Filed by: Beatty Angela
-
Form 4 Gossamer Bio, Inc. For: Mar 04 Filed by: Peterson Caryn
-
Form 20-F RISKIFIED LTD. For: Dec 31
-
Form 4 ZimVie Inc. For: Mar 04 Filed by: Jamali Vafa
-
Form 8-K El Pollo Loco Holdings, For: Mar 06
-
Form 4 Accenture plc For: Mar 05 Filed by: Park Angie Y
-
Form 8-K A.K.A. BRANDS HOLDING For: Mar 06
-
Form 144 JFrog Ltd Filed by: Landman Yoav
-
Form 144 Flutter Entertainment Filed by: Howe Amy
-
Form 4 VERTEX PHARMACEUTICALS For: Mar 04 Filed by: Tatsis Ourania
-
Form 8-K FULL HOUSE RESORTS INC For: Mar 06
-
Form 4 GENERAL DYNAMICS CORP For: Mar 05 Filed by: Wall Peter A
-
Form 424B2 UBS AG
-
Form 3 Arbutus Biopharma Corp For: Feb 24 Filed by: Androski Lindsay
-
Form 4 JELD-WEN Holding, Inc. For: Mar 05 Filed by: Meier Matthew
-
Form C Daily Dose Cafe, LLC
-
Form 424B2 UBS AG
-
Form 4 ZimVie Inc. For: Mar 04 Filed by: Kanaglekar Indraneel
-
Form 8-K Traeger, Inc. For: Mar 06
-
Form 8-K Contineum Therapeutics, For: Mar 06
-
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 04 Filed by: Sabag Mark
-
Form 4 S&P Global Inc. For: Mar 04 Filed by: Craig Christopher
-
Form 8-K Hewlett Packard Enterpri For: Mar 06
-
Form 8-K Serve Robotics Inc. /DE/ For: Mar 06
-
Form 10-K Xeris Biopharma Holdings For: Dec 31
-
Form 8-K MeridianLink, Inc. For: Mar 06
-
Form 4 Trane Technologies plc For: Mar 05 Filed by: Simmons Donald E.
-
Form 8-K Foghorn Therapeutics For: Mar 06
-
Form 4 Gossamer Bio, Inc. For: Mar 04 Filed by: Christian Waage
-
Form 10-K FIDUS INVESTMENT Corp For: Dec 31
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 144 PG&E Corp Filed by: Williams Stephanie N
-
Form 4 Trane Technologies plc For: Mar 05 Filed by: Turtz Evan M
-
Form 4 COMMERCE BANCSHARES INC For: Mar 04 Filed by: JAKOVICH KIM L
-
Form 8-K FINANCIAL INSTITUTIONS For: Mar 04
-
Form 144 INTUITIVE SURGICAL INC Filed by: Brosius Mark
-
Form N-CSR MORGAN STANLEY INDIA For: Dec 31
-
Form 424B2 UBS AG
-
Form 4 Gossamer Bio, Inc. For: Mar 04 Filed by: Smith Robert Paul JR

